The recent popularity of solution SAXS in structural investigations of proteins and other biomolecules has resulted from algorithmic advances, availability of synchrotron radiation and commercial laboratory instruments, and the changing needs of structural biologists 1 . Although crystallography has for many years been the primary choice in structural biology, the challenges of crystallizing increasingly complex biomolecules have necessitated new experimental approaches. At the same time, many structural studies require insight into conformational changes under physiologically relevant conditions that are difficult to access by other methods. Given these challenges, a solution-based structural technique that provides even low-resolution information is compelling. SAXS provides an excellent avenue in these cases. Although limited by resolution (~10-50 Å d-spacing), SAXS is not limited to biomolecules of a certain size, unlike electron microscopy or nuclear magnetic resonance (NMR) 2 . SAXS can thus offer unique insight into functionally important conformational changes of various biomolecules 2 , including complex formation 3 , interconversions of multiple allosteric states 4 , movements of flexible domains 5 and macromolecular foldingunfolding 6, 7 . Furthermore, such changes can be studied as a function of solution condition (e.g., ligand concentration, temperature, pressure) or even time. The versatility of SAXS makes it a powerful complementary technique even when high-resolution information is available from other methods 8 .
IntroDuctIon
The recent popularity of solution SAXS in structural investigations of proteins and other biomolecules has resulted from algorithmic advances, availability of synchrotron radiation and commercial laboratory instruments, and the changing needs of structural biologists 1 . Although crystallography has for many years been the primary choice in structural biology, the challenges of crystallizing increasingly complex biomolecules have necessitated new experimental approaches. At the same time, many structural studies require insight into conformational changes under physiologically relevant conditions that are difficult to access by other methods. Given these challenges, a solution-based structural technique that provides even low-resolution information is compelling. SAXS provides an excellent avenue in these cases. Although limited by resolution (~10-50 Å d-spacing), SAXS is not limited to biomolecules of a certain size, unlike electron microscopy or nuclear magnetic resonance (NMR) 2 . SAXS can thus offer unique insight into functionally important conformational changes of various biomolecules 2 , including complex formation 3 , interconversions of multiple allosteric states 4 , movements of flexible domains 5 and macromolecular foldingunfolding 6, 7 . Furthermore, such changes can be studied as a function of solution condition (e.g., ligand concentration, temperature, pressure) or even time. The versatility of SAXS makes it a powerful complementary technique even when high-resolution information is available from other methods 8 .
Despite its promise, SAXS remains a technique with a steep learning curve. The goal of this protocol is to guide nonspecialists with a general approach to avoid common problems in SAXS data collection and analysis. To help familiarize the reader with SAXS data, we provide example data (Supplementary Data) that are discussed in detail in the ANTICIPATED RESULTS section. In addition, to familiarize the reader with data processing before a SAXS experiment, we provide notes on how to perform key steps in the user-friendly open-source program RAW 9 , for which detailed video tutorials are available online (http://sourceforge. net/projects/bioxtasraw/). We note that the exact data collection procedure (e.g., exposure times, number of exposures, averaging versus summing of exposures, degree of automation) will depend on the sample and beamline. We describe the procedure for performing SAXS manually, which we believe represents the basic form of the technique and illustrates fundamental concepts that are common to all SAXS experiments. The general workflow and the troubleshooting guide presented here can be easily adapted to beamlines outfitted with automation or other instrumentation. Likewise, although the protocol introduced here is focused on synchrotron-based SAXS of proteins, it can be modified for use with commercial lab instruments or other soluble biomolecules, such as nucleic acids 10 . The reader is referred to the many excellent reviews for extended discussions of SAXS theory, data collection and analysis, and applications of the technique 2, 8, [11] [12] [13] [14] .
Interpretation of SAXS Data
As in X-ray crystallography, SAXS derives structural information from the interaction of X-rays with the 3D distribution of electrons in a sample 14 . In a typical SAXS setup, a collimated, monochromatic beam incident on a sample scatters onto a 2D detector, giving rise to a diffuse pattern (Fig. 1) . Data collection requires two measurements: one of the protein solution and one of the background solution (usually a buffer). Because proteins in solution are randomly oriented, the scattering pattern represents an average of the scattering from all possible orientations. Hence, the scattering intensity recorded on the 2D detector will not depend on the direction of the scattering vector, but only on its magnitude, q = (4π sin θ)/λ, where 2θ is defined as the scattering angle and λ is the wavelength of the incoming X-ray beam. The 2D images can thus be integrated about the beam Synchrotron-based small-angle X-ray scattering of proteins in solution Soren Skou 1 , Richard E Gillilan 2 & Nozomi Ando 3 center to produce 1D curves, called scattering profiles, defined as scattering intensity I versus q, where q is typically given in units of inverse angstroms or inverse nanometers. The scattering contribution of the protein on its own is then produced by subtracting the buffer scattering profile from the proteinsolution scattering profile. This background-subtracted profile is the starting point for the analysis of solution SAXS data. A wealth of structural information can be gained from such profiles, including radius of gyration (R g ), molecular mass, foldedness and flexibility, overall 3D shape, polydispersity and maximum intraparticle distance (D max ) 2, 8, 14 .
However, compared with crystal diffraction data, SAXS data are relatively featureless and highly sensitive to experimental technique and sample quality. Common problems such as nonspecific protein aggregation, polydispersity and poor background subtractions can severely limit the interpretability of data. To minimize the chances of buffer mismatch between the protein solution and the background solution, rigorous buffer exchange should be performed. The sample purity, stability and conformational heterogeneity should also be characterized by other techniques (e.g., SDS-PAGE, chromatography, dynamic light scattering, multiangle light scattering and analytical ultracentrifugation) before performing SAXS. Caution must also be exercised in the interpretation of data. In particular, it is important to recognize that structural parameters (such as R g , mass and D max ) and 3D envelopes obtained by ab initio shape reconstruction methods do not correspond to specific structural states unless the sample is monodisperse to begin with. It is also noted that the value of D max is inferred by solving the inverse Fourier transform of the scattering profile with D max as an adjustable parameter 14, 15 , and it is hence sensitive to sample quality 8 and difficult to estimate with accuracy.
Despite the challenges in data interpretation, a major strength of SAXS is that there are multiple, independent ways to arrive at the same conclusion. For example, both R g and mass information can be derived by Guinier or pair-distance distribution analysis (as later discussed in the PROCEDURE). In addition, several software packages exist for the analysis of the integrated scattering profiles 9, [16] [17] [18] , including the widely used ATSAS package, which contains tools for 3D shape reconstructions, protein flexibility analysis, analysis of mixtures of oligomeric species and the calculation of SAXS profiles from crystal structures. Thus, confidence in data interpretation can be gained by demonstrating consistency in multiple lines of analysis.
Experimental variables
Sample cells for SAXS typically have path lengths of 1-3 mm, requiring sample volumes on the order of 10-40 µl. Depending on the beamline, samples may be loaded manually using pipettes or automatically through robotics or microfluidics [19] [20] [21] [22] [23] [24] . The protein concentration (in mg/ml) needed for a given signal-to-noise ratio is inversely proportional to molecular mass. Thus, although a 14-kDa protein might require 2.5 mg/ml to give a useful signal, a 66-kDa protein would require only ~0.5 mg/ml. However, SAXS is a technique that is sensitive to solution nonideality. Interference of X-rays scattered from particles interacting in solution can distort the scattering profile, particularly at low q. Because interparticle interactions are concentration-dependent, measurements must be made at multiple protein concentrations for every protein of interest. Concentration effects can be subtle, and failure to examine these effects can lead to incorrect estimation of the structural parameters. Other techniques that are sensitive to solution nonideality, such as analytical ultracentrifugation, can aid in the optimization of solution conditions before an SAXS experiment.
The optimal exposure time ranges from less than a second to a couple of minutes, depending on the available X-ray intensity and the sample's susceptibility to the X-rays 25 . The determination of the optimal exposure time generally entails collecting multiple, short exposures per sample and then identifying the accumulated exposure at which radiation damage begins to appear in the scattering profiles (as later discussed in the PROCEDURE). Increasing exposure times can increase the signal-to-noise ratio, but they will also increase the risk of radiation damage. Some beamlines offer a flow cell with constant movement of the sample to reduce damage during exposure. Owing to the physics of pressure-driven flow inside the flow cell, however, the flow velocity at the cell walls will be theoretically zero. Thus, even with constant flow, build-up of damaged protein is inevitable, and the cell should be cleaned thoroughly between samples. Radiation damage will most often present itself as aggregation, which can severely limit the interpretability of data.
Preparing for data collection
Connecting with a beamline. Readers can locate a convenient facility by visiting the lightsources.org website (http://www. lightsources.org/). Most synchrotron sources worldwide provide beamtime for biological SAXS via a rapid-access proposal mechanism. Potential users should consult beamline personnel to discuss the feasibility of their project, training options and beamlinespecific procedures. Many synchrotrons offer annual workshops on biological SAXS. In addition, major laboratory X-ray hardware companies offer home-source biological SAXS instrumentation that is becoming increasingly common at academic institutions.
Beamline settings. Generally, beamline personnel will perform the setup and calibration of the beamline and provide the beamline settings needed for processing raw detector files. A collimated, monochromatic X-ray beam incident on the sample generates scattered X-rays, which are imaged by a detector. The transmitted beam is usually blocked by a beamstop, resulting in a shadow in the image. The scattering vector, q, describes the change in direction of the elastically scattered X-rays, and it is roughly parallel to the detector face in the small-angle approximation. The images are integrated to yield scattering intensity as a 1D function of q. The scattering intensity can also be expressed as a function of s = q/2π, which is equivalent to 'resolution' or d-spacing in crystallography. Because q and s are often used interchangeably in the literature, the exact usage should be explicitly defined in any publication with SAXS data.
Although it is recommended that users process data on-site at the time of collection, it is occasionally necessary to re-process data at home. Calibration steps are thus described in the PROCEDURE (Steps 12-17) to guide the user in generating beamline settings from calibration files. Users should obtain copies of these files and other necessary information for performing these steps from beamline personnel.
Transport of samples.
It is always advisable to prepare samples as immediately before data collection as possible. Samples that can remain monodisperse at 4 °C for periods of days to weeks should be shipped unfrozen on ice packs. Freezing can effectively arrest degradation and even time-dependent aggregation, but samples vary in their tolerance toward freezing, so care should be taken. Even when shipping frozen samples (on dry ice or in liquid nitrogen), it is advisable to reserve some unfrozen sample for comparison. Cryoprotectants are only acceptable in low concentrations (see Reagent Setup), although on-site buffer exchange and even size-exclusion chromatography are options at many beamlines.
Experimental design
As described above, it is important to examine the concentration effects for every protein of interest. An overview of preparing a concentration series is described in Supplementary Figure 1 .
Another useful type of experiment is a titration, in which the protein concentration is fixed and another ingredient is present at various concentrations. Such an experiment is useful for optimizing the solution condition. For example, if interparticle repulsion is observed at a protein concentration of interest (as discussed in the PROCEDURE and TROUBLESHOOTING), concentrated salt solutions may be used to determine an optimal ionic strength. Titration experiments are also useful for characterizing conformational changes caused by a small-molecule ligand 4 or another protein 3 . Note that if a small-molecule ingredient is added to the protein solution, it must also be added to the buffer solution.
As discussed in the PROCEDURE, the background buffer is best matched by performing a buffer exchange of the protein solution. However, if buffer exchange is not possible, accurate pipetting is essential. REAGENT SETUP Buffer requirements SAXS is compatible with many common biological buffers and solution conditions. Note, however, that highly electron-dense buffers (e.g., having >15% glycerol or excess metallocofactors) can lead to poor scattering contrast between the protein and the background. In general, the buffer should be as dilute as possible, while having sufficient buffering strength and containing all ingredients at levels necessary for protein stability, homogeneity and activity. Note that if the protein is highly charged at the buffer pH, the addition of salt is probably needed to reduce interparticle effects on the scattering. The addition of glycerol, ethylene glycol or sucrose at low concentrations (~1% wt/wt) to the buffer has been shown to reduce radiation damage 26 . Common reducing agents such as DTT and TCEP are thought to provide similar protection. Protein requirements SAXS is extremely sensitive to sample quality. Before visiting a synchrotron, the protein homogeneity should be characterized under the conditions that will be used for SAXS experiments by other techniques (e.g., SDS-PAGE, size-exclusion chromatography, analytical ultracentrifugation, dynamic light scattering, multiangle light scattering). By our estimates, the purity should be at least 95% by SDS-PAGE (as in crystallography). Note that because scattering signal is a function of molecular
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• mass, even a small population of aggregates, high-order oligomers or large impurities can significantly alter SAXS data. To reduce the chances of aggregation, it is generally recommended that samples be prepared as close to the time of use as practically possible. Samples that have been stored for substantial periods of time should be subjected to size-exclusion chromatography before use. Protein standards Proteins that have been previously characterized by SAXS are useful for molecular-weight determination and for evaluating the beamline setup. Beamline personnel may provide protein standards, or users can prepare their own 27, 28 . It is strongly advisable that protein standards be freshly prepared before use. Examples include 4.0 mg/ml hen egg white lysozyme (EMD Millipore, cat. no. 5950-OP; 14.3 kDa, R g = 14.3 ± 0.4 Å) in 40 mM sodium acetate (pH 4.0), 50 mM NaCl, 1% (vol/vol) glycerol and 0.3 mg/ml glucose isomerase (Hampton Research, cat. no. HR7-100; 173 kDa, R g = 32.5 ± 0.7 Å) in 10 mM HEPES (pH 7.0), and 1 mM MgCl 2 (refs. 28,29) . Note that some proteins, such as BSA and HSA, are prone to oligomerization and hence are not recommended as SAXS standards. Cleaning solutions To properly subtract the contributions of the sample cell to the background scattering, protein and buffer exposures should be collected using the same cell. In between different samples, the cell must be cleaned and dried. Suitable cleaning solutions include deionized water, detergent (e.g., 2% (vol/vol) Hellmanex), bleach and ethanol. If cleaning solutions are not provided by the beamline, consult with beamline personnel about solutions that are compatible with the sample cell.
EQUIPMENT SETUP Beamline setup
The typical user does not need to be directly involved in the setup of a SAXS beamline. However, before a synchrotron visit, the user should discuss specific needs (e.g., resolution limit, light sensitivity, oxygen sensitivity, temperature settings, detectors) with beamline personnel. Check with beamline personnel about the availability of wet-lab tools, such as pipettes, disposables, tube racks, centrifuges, refrigerators, freezers, chromatography equipment, spectrophotometers and deionized water. Software requirements and setup Software is needed for reading, displaying, integrating and correcting detector-specific scattering images. The integrated data must also be normalized by the X-ray dose (typically measured by a PiN-diode beamstop). Unlike laboratory X-ray sources, which can be quite stable, synchrotron intensity can fluctuate and even decay over time, necessitating careful matching of actual doses. In addition to these minimum requirements, software is needed to subtract and average multiple 1D curves and perform linear fits. Suitable software may be available at the beamline. Alternatively, readers may use RAW 9 by following the detailed installation and configuration instructions at http://sourceforge.net/projects/bioxtasraw/.
proceDure preparing samples for a synchrotron trip • tIMInG 1-2 d 1| Prepare a concentrated stock buffer solution (e.g., '10× buffer', a stock solution at tenfold the working concentration of the buffer) and filter-sterilize it with a 0.2-0.45-µm-pore membrane. Do not add ingredients that can degrade over time (e.g., reductants that may oxidize or nucleotides that can hydrolyze).
2|
Use the concentrated stock buffer solution from
Step 1 to prepare a large volume of buffer at the working concentration, adding additional ingredients that are necessary for protein stability (but that were not included in Step 1). Filter the freshly diluted buffer and store the remaining concentrated stock buffer solution appropriately.
3| Use freshly diluted buffer from
Step 2 to perform a buffer exchange of the protein solution. If the buffer components and protein are stable overnight, dialysis is an appropriate method. Alternative methods include desalting and size-exclusion chromatography.  crItIcal step The interpretability of SAXS data is critically dependent on the quality of the background subtraction, which requires an exact buffer background match.
4|
Save at least 50 ml (or the minimum volume recommended by beamline personnel) of the final dialysate or elution buffer from Step 3. This buffer will be used for background measurements, dilutions and sample cell cleaning at the synchrotron. In cases of size exclusion, the original reservoir buffer or the buffer from a well-equilibrated column is recommended.
5|
Prepare a protein stock solution by concentrating the buffer-exchanged protein solution from Step 3. As discussed above, typical concentrations for SAXS are in the 1-10 mg/ml range, although the minimum concentration required for sufficient scattering signal is inversely proportional to the molecular mass. Consult with beamline personnel as needed.
6|
Check the final protein concentration as accurately as possible. Errors in concentration can be a major source of error in molecular-weight estimation. Although no method is universally applicable, UV absorption at 280 nm (A 280 method) is widely used (when applicable) to quantify protein concentration, and it is accurate to ~10%. Potential lack of aromatic residues, the presence of interfering additives or ligands and inaccuracies in computed extinction coefficients are complicating factors. Although protein concentration is often reported in mg/ml in the SAXS literature, it is also useful to report molar concentrations if comparisons with the biochemistry literature are important.
7|
If the proteins must be frozen for storage, divide the protein solution from
Step 5 into small volumes that can be thawed as needed. Avoid the introduction of air bubbles, and centrifuge the solutions before flash-freezing them in liquid nitrogen.  pause poInt Store the frozen aliquots in liquid nitrogen or in a −80 °C freezer until shipping. Coordinate with synchrotron personnel on appropriate shipping and receiving dates.
8| Use the buffer from Step 4 to prepare concentrated solutions of any small-molecule additives that will be later added to protein samples (e.g., ligands, salts, reductants). Concentrated salt solutions are useful for titrations if the protein has not been previously characterized by SAXS and the optimal ionic strength is not known. If the additive is not soluble in buffer at high concentrations, dissolve it in deionized water.
9| Prepare aliquots of the additive solutions from
Step 8 and the buffer from Step 4. Store the aliquots appropriately. Freeze them if there are components that can degrade (e.g., oxidize, hydrolyze).  pause poInt Store the frozen aliquots in liquid nitrogen or in a −80 °C freezer until shipping.
10| Transport or ship samples to the synchrotron with appropriate packaging (e.g., with ice, dry ice or liquid nitrogen). Items to include are: protein stock solutions (from Steps 5 or 7, if frozen), matched buffer solutions (from Step 9), additive solutions (from Step 9) and 5-10 ml of concentrated stock buffer solution (from Step 1).
11|
Upon their arrival at the synchrotron, samples should be stored at an appropriate temperature (e.g., in a cold room, freezer or Dewar containing liquid nitrogen). Note that for samples transported on dry ice, accumulated CO 2 gas must be allowed to diffuse out from sample containers 30 .
preparing for data collection • tIMInG 1 h  crItIcal Steps 12-17 are generally performed by beamline personnel or with the help of personnel.
12|
Configure the data reduction program to read and display the images generated by the detector.
13| Take X-ray exposures with an empty sample cell at several exposure times. Open the images in a data reduction program and visually check that they are absent of unusual background scattering or diffuse shadows. Make note of all sharp shadows (including that of the beamstop) and pixels with unusually high (saturated)-or low (dead)-intensity readings.
14|
Create an integration mask in the data reduction program by outlining regions in the images that should not be included in integration (e.g., shadows and dead pixels from Step 13). In RAW, masks are built by selecting mask shapes and dragging them onto the image. Right-clicking a mask and selecting 'inverted mask' will mask out everything but the selected mask.
15| Take exposures with a periodic calibrant (e.g., silver behenate powder) in the sample cell. These calibrants should be provided by beamline personnel.
16| Determine the coordinates of the beam center and the sample-to-detector distance in the program using the lattice constant of the calibrant and the positions of the diffraction rings. Some beamlines may directly image the position of the beam center by attenuation or by a semitransparent beamstop. Check that the calculated distance agrees with a physical measurement of this distance (e.g., one made with a tape measure). In RAW, automated calibration is initiated by opening the Centering/Calibration panel, clicking the 'Start' button under Automatic Centering and clicking on three or more points just outside of the innermost diffraction ring.
17| Configure the data reduction program to convert images into 1D transmission-normalized scattering profiles (I versus q).
In RAW, image integration is automatically performed as the images are generated.
18| Document the X-ray energy, sample-to-detector distance, beam size, flux at the sample, a description of the beamline (e.g., the sample cell and detector) and other information relevant for publication 12 . With the help of beamline personnel, determine how filenames of detector images and other files necessary for data processing are produced. Prepare to create a detailed log of samples and corresponding filenames when collecting data. Several hundred exposures can be produced in a single visit, and good record keeping is crucial. If possible, choose a descriptive naming scheme that provides additional documentation.
19| Plan experiments and sample recipes (supplementary Figure 1) . Start with a protein standard at a known concentration before performing experiments with the protein of interest. Consult with beamline personnel to determine sample volumes and exposure times.
General steps for collection of a single data set • tIMInG 15-30 min 20| Thaw any frozen stock solutions needed for the experiment.  crItIcal step Do not vortex or shake protein solutions vigorously, and avoid repeated freeze-thaw cycles, as aggregates may form.
21|
While using proper pipetting techniques, prepare both a protein sample at a particular concentration and a matching buffer solution, which contains all ingredients except the protein.
Keep the samples at a suitable temperature (e.g., on ice).  crItIcal step It is essential that any ingredients added to the protein solution also be added to the buffer solution.
If any additive stock solutions were made in water (in Step 8), use the concentrated stock buffer solution to compensate for the dilution of the buffer. At all times, buffer composition must match what is found in the sample solution as closely as possible (to better than 1% accuracy). Generally, it is not advisable to depend upon pipetting accuracy to make up matching buffer, but rather to exchange buffer as described in Step 3.
22| Load the buffer solution prepared in
Step 21 into a clean, dry sample cell without introducing air bubbles. Loading and emptying a sample cell may be performed by manual pipetting or by an automated system, depending on the beamline.  crItIcal step To avoid introducing air bubbles when pipetting, dispense the liquid slowly and avoid depressing the plunger beyond the first stop.
23| Take multiple short exposures and look for any unusual scattering in the detector images as they are generated. Note that the low readout noise of photon-counting detectors allows for large numbers of exposures to be collected and merged by averaging or summing. The use of integrating detectors (such as conventional charge-coupled device (CCD) cameras) limits the number of frames that can be merged, owing to the accumulation of readout noise. Consult with beamline personnel to determine how many exposures are recommended.
24|
Plot the buffer scattering profiles in the data reduction program and check that most, if not all, of the buffer profiles are superimposable to within the experimental noise level. In some automated systems, a χ 2 statistic is used as a criterion for rejection.
? trouBlesHootInG 25| Average the buffer profiles that are superimposable in the data reduction program. Check that the average curve is centered among the individual profiles. To average multiple curves in RAW, select the profiles in the Manipulation list with the shift or control key, and then click on the 'Average' button.
26|
Remove the buffer, rinse the sample cell with cleaning solutions (e.g., ethanol, water, detergent) and dry the cell. The goal of cleaning at this step is to prevent buffer residues from forming in the sample cell during the drying step. Cleaning solutions compatible with the sample cell should be provided by the beamline facility.
27| Remove air bubbles, aggregates and other particulates from the protein solution (prepared in
Step 21) by filtration or centrifugation. To use a centrifugal filter, rinse the membrane as instructed by the manufacturer, and then rinse it with buffer and remove the buffer completely before filtering the protein solution. Alternatively, centrifuge the solution (16,000g at 4 °C for 10 min) and remove the supernatant.
28|
Repeat Steps 22-24 with the protein solution. Check for any time-dependent changes in the shape of the curves. Overlay the individual protein-solution scattering profiles with the averaged buffer profile from Step 25 and check that they do not cross over (beyond statistical fluctuations) at high q. ? trouBlesHootInG 29| Average the protein-solution profiles that are superimposable by following the same procedure used in Step 25. Exclude profiles that exhibit time-dependent changes in scattering, particularly at low q. Note that although averaging improves the signal-to-noise ratio, it is not required for further data processing, and there are certain cases in which averaging may not be preferred (see Step 32) . ? trouBlesHootInG 30| Remove the protein sample and repeat the cleaning procedure in Step 26.
31|
Repeat Steps 22-26 with the buffer. Check that the buffer profiles before and after the protein exposures are superimposable.
? trouBlesHootInG Background subtraction and initial inspection • tIMInG 5 min 32| Subtract the averaged buffer profile (from Step 25) from the averaged protein-solution profile (from Step 29) . To do this in RAW, mark the buffer profile by clicking on the adjacent star icon, select the protein-solution profile in the Manipulation list and click on the 'Subtract' button. This averaged, subtracted scattering profile will be used for subsequent analyses. Note that emerging SAXS methods, such as in-line size-exclusion chromatography 21 , may require that buffer subtraction be performed on individual exposures (generated in Step 28) rather than on the average (from Step 29) . In addition, users may wish to monitor structural parameters for each exposure. In such cases, it is recommended that subtractions be performed with a buffer profile of a comparable or lower experimental noise level than the protein-solution profiles (e.g., the averaged buffer profile from Step 25) .  crItIcal step Save subtracted data curves and/or obtain the necessary software settings from beamline personnel needed to repeat any data reduction at home. ? trouBlesHootInG 33| Plot the buffer-subtracted profile as log(I) versus q and inspect the shape. The semi-log plot of a typical, well-behaving protein will have a characteristic bell-like shape in the low-q region. Alternatively, plot the subtracted profile as log(I) versus log(q), which should intersect the vertical axis roughly perpendicularly.
? trouBlesHootInG Guinier analysis • tIMInG 5-15 min 34| Plot the subtracted profile from Step 32 as a Guinier curve (ln(I) versus q 2 ) and zoom into the low-q region (the maximum q 2 should be <0.01 Å −2 for most proteins). Check that the Guinier curve appears linear at low q with no obvious upturn or downturn. For a monodisperse solution of a protein with a well-defined size, this region should be linear 12 . To examine Guinier curves in RAW, right-click on the profile in the Manipulation list, select 'Guinier fit' in the pop-up menu and adjust the axis ranges in the Guinier fit window that appears.
? trouBlesHootInG 35| Perform a linear fit to the low-q region of the Guinier curve. The maximum q that is generally acceptable to include in the fit is 1.3/R g , where R g is the radius of gyration of the protein 12 . A small number of noisy data points in the beginning may be omitted from the fit, but any significant nonlinear trends should be reported in publications. The slope of the line is equal to −R g 2 /3, and the vertical intercept is equal to the natural log of the zero-angle scattering intensity I(0). In RAW, adjust the maximum q in the Guinier fit window until the displayed qR g value is 1.3 or less and the residuals of the fit (displayed in the bottom panel) are randomly distributed around zero. 
40|
Open the ASCII file in the cross-platform version of PRIMUS 17 (PRIMUS Qt) from the ATSAS package and select 'Distance Distribution' from the Tools menu. The resultant window will call the program GNOM 15 , which generates the Fourier transform of I(q): the pair-distance distribution function, P(r), which represents a continuous r 2 -weighted histogram of all electronpair distances, r, in the protein. In this process, the program will automatically optimize the q-range included in the analysis and estimate the maximum dimension of the protein D max . If P(r) is severely negative or highly extended at high r, the data may not be suitable for further analysis.  crItIcal step This step is designed to provide an initial guess for D max for the non-expert user, and it is generally not recommended to automate D max estimation. ? trouBlesHootInG
41|
In the same GNOM window, release the default condition that fixes P(r) to zero at high r. If P(r) no longer converges to zero at high r, manually adjust D max and the q-range included in the analysis (q min to q max ) until P(r) naturally approaches zero. The q min value can be adjusted to exclude data that exhibit interparticle effects or noise, but it should not exceed the value set by the so-called Shannon limit 32 (q = π/D max ). The q max value can be adjusted to avoid overfitting low signal-tonoise data in the high-q region. P(r) of high-quality data with negligible interparticle effects will not only converge to zero at high r at a certain D max , but it will also remain converged even when D max is further increased. The reader is referred to the literature 8 for an excellent review of D max estimation. ? trouBlesHootInG 42| Save the output file from Step 41.  crItIcal step Note that Steps 40 and 41 can also be performed by using the standalone versions of DATGNOM 33 and GNOM 15 , respectively. In all cases, an output file will be generated with the results from the set of parameters that were tested last. The output file will also include a rating of 'suspicious', 'reasonable', 'good' or 'excellent' on the basis of the quality score known as the 'total estimate' . Although acceptable solutions should be rated 'reasonable' or better, it is important to visually inspect the shape of P(r) and the corresponding fit to I(q).
43|
Compare the R g and I(0) determined from P(r) (Step 40 or 41), with the corresponding values determined by Guinier analysis (Step 37). The values should agree within error.
44|
In a spreadsheet or graphing program, plot the R g and I(0) values determined by each method (P(r) and Guinier) at three or more protein concentrations. For each plot, the trends should appear roughly linear over a concentration range. If the trends increase significantly or nonlinearly with increased concentration, it is likely that the protein is a mixture of oligomers or is aggregated.
? trouBlesHootInG 45| Fit a line to the plot of R g versus concentration (for each method, P(r) and Guinier). The vertical intercept of this line is the R g extrapolated to infinite dilution.  pause poInt Further analyses can be performed at home. Once a reasonable P(r) has been obtained, the output file from
Step 42 can be used in ab initio shape reconstruction programs. It is important to note that shape reconstructions are not meaningful unless the homogeneity of the sample has been demonstrated by other methods. Note also that to perform shape reconstructions in DAMMIF or DAMMIN 34,35 the recommended limit for the maximum q in P(r) analysis is 8/R g . Finally, estimate molecular mass with another method, if possible. Mass can be estimated without a protein standard by putting I(0) on an absolute scale 31 . Mass can also be estimated without concentration information by using one of several methods based on integral invariants 14, [36] [37] [38] . Mass estimates should agree to within an expected error of ~10%.
? trouBlesHootInG Troubleshooting advice can be found in table 1. 
antIcIpateD results
The protocols introduced here are demonstrated by data collected on HSA. 1 liter of buffer (50 mM HEPES (pH 7.5), 100 mM NaCl) was prepared, filtered (Nalgene Rapid-Flow, 0.2-µm polyethersulfone) and degassed. Lyophilized HSA (Sigma-Aldrich, cat. no. A8763) was dissolved in the buffer at a concentration of ~10 mg/ml and filtered (Corning Spin-X, 0.22-µm cellulose acetate). Buffer exchange was performed in two ways. In the first method, HSA was separated from small molecules (e.g., stabilizers introduced in the lyophillization process) by using a disposable desalting column (GE Healthcare, cat. no. PD-10).
In the second, monomeric HSA was separated from both small molecules and oligomeric forms of HSA by size-exclusion chromatography (GE Healthcare, Superdex 200) (Fig. 2) . The eluted proteins were concentrated by using centrifugal concentrators (GE Healthcare, Vivaspin 6, 30-kDa MWCO), and the final concentration was determined from the absorption at 280 nm (ref. 39 ). Samples were loaded in an in vacuo oscillating flow cell 22 . Scattering images were collected on a fiber optic-coupled CCD detector 40 and were corrected 41 , integrated and normalized by the transmission intensity to generate 1D scattering profiles, (a) The scattering profiles of unpurified HSA (red curves, from bottom to top: 1.9, 3.8, 6.5 mg/ml) and purified HSA (black curves, from bottom to top: 1.9, 3.8, 6.5, 15.9 mg/ml) show no signs of aggregation, which would appear as upturns in the lowest q portion of a profile. (b) When plotted as Guinier curves, the absence of upturns at low q is clear. In addition, the effect of the final purification step is evident: for a given concentration, the slope and vertical intercept of unpurified HSA are greater, consistent with the presence of species larger than a monomer. Finally, concentration effects can be seen, particularly in the case of purified HSA. With increasing concentration, a greater downward curvature is observed at low q, which is consistent with interparticle repulsion. I versus q (supplementary Data). Typical scattering profiles before buffer subtraction are shown in Figure 3 . The effect of buffer mismatch is shown in Figure 4 . After inspection of the profiles, averaging and buffer subtraction was performed as described in the procedures. The importance of sample homogeneity is demonstrated by data collected on HSA. Although the lyophilized HSA used here is ≥99% pure in terms of protein content, HSA is known to form oligomers through intermolecular disulfides, which must be separated by size exclusion 42 (Fig. 2) . Notably, the buffer-subtracted profiles and the corresponding Guinier curves of unpurified HSA show no obvious problems (Fig. 5a,b, red) . However, subtle differences are apparent when compared with the scattering profiles of purified HSA (Fig. 5a,b, black) . For a given concentration (in mg/ml), both the vertical intercept and slope of the Guinier curves are slightly greater when size exclusion is not performed (Fig. 5b) , consistent with the presence of oligomers in these samples.
The importance of examining multiple protein concentrations is also demonstrated by these data. Interparticle interactions occur over large length scales, and hence they distort scattering profiles in a concentration-dependent manner at low q, where Guinier analysis is performed (Fig. 6) . In the case of HSA, the R g values determined by Guinier analysis decrease roughly linearly with increasing concentration (Fig. 7a) , a trend that is consistent with interparticle repulsion arising from excluded volume effects 10, 43 . Linear fits to these trends yield R g values extrapolated to infinite dilution (i.e., where interparticle effects are minimized) of 28.7 ± 1.1 Å and 32.7 ± 4.4 Å for purified and unpurified HSA, respectively. Here, the error estimates represent the 95% confidence intervals from the fits. In the case of I(0), a linear trend is observed for samples over the 1.9-6.5 mg/ml range (Fig. 7b) . The I(0) value for purified HSA at 15.9 mg/ml, however, falls short of this linear trend. Inspection of the Guinier curve for this sample shows that I(0) is underestimated because of a subtle downward curvature in the low-q region owing to interparticle repulsion (Fig. 5b) .
The effects of interparticle interactions and polydispersity are very evident in the pair distance distribution P(r) (ref. 8 ). Because of the reciprocal relationship of r and q, interparticle effects at low q affect the high-r portion of P(r). Aggregates or oligomers, such as those found in unpurified HSA solutions, can lead to an artificially high D max (Fig. 8,  dotted) , and in the worst cases P(r) will not converge to zero at high r. Conversely, interparticle repulsion, such as that observed for purified HSA at 15.9 mg/ml, will lead to negative P(r) at high r (Fig. 8, blue) . Dilution of HSA leads to P(r) curves that are nearly superimposable, except at high r where the curves become less negative (Fig. 8, blue to red) . This trend is consistent with the reduction of interparticle effects. At 1.9 mg/ml, these effects are negligible, resulting in a P(r) curve that tends smoothly toward zero with a welldefined D max (Fig. 8, red) . The sensitivity of P(r) to interparticle interactions and polydispersity makes this analysis a useful step in inspecting data quality. After these analyses, ab initio shape reconstructions can be performed for data collected on homogeneous samples with negligible interparticle effects. In the case of HSA, homogeneity is achieved with size-exclusion chromatography , is sensitive to concentration effects and sample polydispersity. Here PRIMUS 17 was used to automatically generate the P(r) of purified HSA (solid curves, from red to blue: 1.9-15.9 mg/ml) and unpurified HSA at 1.9 mg/ml (dashed curve). Interparticle repulsion leads to negative regions at high r, which leads to an artificially low D max . The presence of aggregates or higher-order oligomers extends P(r) at high r, leading to an artificially high D max . (Fig. 2) , and interparticle effects are minimized through serial dilutions (Figs. 7a and 8) . However, dilute samples that exhibit nearly ideal solution behavior may not have sufficient signal-to-noise levels at high q needed for shape reconstructions and other types of analyses (e.g., Kratky and Porod exponent analyses). In such cases, it is possible to apply extrapolation methods that combine data collected at multiple concentrations if it can be shown that the sample does not appreciably change its conformation 17, 31 . This assumption is not necessarily valid in all situations. Merging or extrapolation operations should thus be performed with caution, and they should always be reported 12 .
In the case of purified HSA, the P(r) curves are largely identical at all concentrations except at high r (Fig. 8, solid) , indicating that there are no appreciable conformational changes. Equivalently, the I(q) curves are also superimposable except at low q. Low-q data from 1.9 mg/ml purified HSA (q range of .008-0.045 Å −1 ) was thus merged with higher-q data from 3.8 mg/ml purified HSA (q range of .035-0.22 Å −1 ) in PRIMUS 17 (Fig. 9a, gray) . A smooth curve was fitted (Fig. 9a,  black) to the data in GNOM 15 , producing a P(r) curve that converges smoothly to zero at high r. Because shape reconstructions do not yield unique solutions, ten bead models were thus reconstructed in DAMMIF 35 (supplementary Video 1), aligned and averaged in DAMAVER 44 to produce a most probable model and refined in DAMMIN 34 to produce the final SAXS envelope (Fig. 9b, surface) . It is important to note that the solution conformation of a protein does not have to agree with the conformation observed in crystal structures. In the case of HSA, however, the final SAXS envelope of monomeric HSA (as determined by size exclusion) shows good agreement with the crystal structure of the HSA monomer 45 (Fig. 9b) . Similarly, the theoretical scattering profile of this crystal structure 45 generated in CRYSOL 46 also shows good agreement to the experimental profile (Fig. 9a, magenta) . (a) Low-q data from 1.9 mg/ml purified HSA was merged with higher-q data from 3.8 mg/ml purified HSA (shown in gray with standard errors 47 ). A smooth curve was fitted (black) to the data in GNOM 15 that yielded a well-behaved P(r) curve. Ten bead models were reconstructed in DAMMIF 35 , which were aligned and averaged in DAMAVER 44 with no rejections and a normalized spatial discrepancy of 0.874 ± 0.032. The fit of a typical DAMMIF model (green) shows good agreement to the data as does the theoretical scattering profile of a crystal structure 45 (magenta). (b) After averaging in DAMAVER, the 'damstart' model was used for a round of refinement in DAMMIN 34 , yielding the final SAXS envelope (gray), shown superimposed with the crystal structure 45 
